Individuals with type 2 diabetes typically experience an impaired incretin effect, though GLP-1 secretion itself may be normal, slightly reduced, or context-dependent
Research is still emerging, but medically supervised use with regular monitoring appears favorable
How fast can I get medication after switching
These changes reflect better control, not worsening glucose management
Unlike IGF-1 LR3, which has a long half-life (2030 hours) and systemic activity, IGF-DES has a significantly shorter half-life (2030 minutes) but an intense localized effect
How effective is Tirzepatide for weight loss, and what results can I expect before and after treatment